Skip to content

A study on the correlation of pathogenesis of dampness-heat toxin amassment in Chronic Kidney Disease and indoxyl sulfate in gastrointestinal microbiota.

A study on the correlation of pathogenesis of dampness-heat toxin amassment in Chronic Kidney Disease and indoxyl sulfate in gastrointestinal microbiota.

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072955
Enrollment
Unknown
Registered
2023-06-28
Start date
2023-07-01
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure

Interventions

Non-dialysis patients diagnosed with stage 5 CKD.:Not applicable.

Sponsors

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ?Patients aged 18 to 75 years regardless of genders (according to the date of obtaining informed consent). ?Diagnosis of stage 5 CKD before trial. ?No involvement of any dialysis treatments, namely peritoneal dialysis, hemodialysis, as well as continuous renal replacement therapy (CRRT), prior to the study. ?Able to give informed consent and comply with the study protocol voluntarily.

Exclusion criteria

Exclusion criteria: ?Patients with malignant tumors and severe primary diseases, likely cardiovascular, cerebral, hepatic, or hematopoietic system diseases. ?Any medical conditions which put the non-dialysis participants at increased risk ;e.g., the presence of poorly controlled volume overload, hyperkalemia, acidosis, or uremic encephalopathy etc. ?Ongoing antibiotics therapy or suffering from serve infections before trial. ?Unable to comprehend and follow study procedures and instructions. ?Patient’s condition is considered as inappropriate by assigned doctor or investigator. ?Participating in another clinical trial(s) currently.

Design outcomes

Primary

MeasureTime frame
Syndromes of TCM.;Quantitative of serum IS.;Fecal microbiota.;

Secondary

MeasureTime frame
Body Mass Index (BMI);The average daily consumption of protein.;Serum creatinine (SCr).;Blood urea nitrogen (BUN).;Clinical endpoints (including undergoing dialysis, kidney transplantation or death).;

Countries

People's Republic of China

Contacts

Public ContactYongsheng Wang

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)

wys_601@163.com+86 135 6004 8341

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026